Indications
For temporary relief of menopausal symptoms.
Pleo Usti
FDA Label NDC 60681-5604
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Usti (NDC 60681-5604). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications, active ingredient per dose, inactive ingredients, dosage, warning, tamper evident, principal display panel - 10 suppositories carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Active Ingredient Per Dose
0.2 g Ustilago zeae e sporibus rec. 5x.
Inactive Ingredients
hydrogenated palm kernel glycerides, lactose.
Dosage
Once daily, insert one suppository rectally at bedtime.
Warning
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before taking this product.
Tamper Evident
Do not use this product if imprinted inner blister pack is missing or broken.
Principal Display Panel - 10 Suppositories Carton
Pleo™ Usti
SUPPOSITORIES 5X
Homeopathic Medicine
Indications: For temporary
relief of menopausal symptoms.
10 SUPPOSITORIES
Principal Display Panel (10 Suppositories Carton)
* Please review the disclaimer below.
